DEAProposed Rule

Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I

HealthcareOther

Summary

The Drug Enforcement Administration (DEA) is proposing to officially classify cumyl-pegaclone as an illegal drug in the same category as heroin and LSD. This action aims to prevent the spread of a synthetic substance that may pose health and safety risks to the public.

Key Points

  • 1Cumyl-pegaclone would be placed in Schedule I, meaning it would be illegal to make, sell, or possess without a special government license
  • 2This is a proposed rule, so the public has until January 13, 2026 to submit comments or concerns before the DEA makes a final decision
  • 3The substance appears to be a synthetic drug with no approved medical uses, similar to other designer drugs that manufacturers create to get around existing drug laws
  • 4If approved, people caught with this drug could face federal criminal penalties, including fines and imprisonment
  • 5The DEA likely took this action because the drug is becoming more available or causing public health concerns in communities

Key Dates

Published

December 11, 2025

Comment Deadline

January 13, 2026

Google Cal

This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.

The Digest Network

AI Comment Drafter

Describe your concern and we'll help you draft a substantive comment.

AI-generated draft. Always review and edit before submitting. Replace all [bracketed placeholders] with your specific details. Your comment should reflect your genuine views and experience.